Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from PCT/US1989/004732external-prioritypatent/WO1990004641A1/en
Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents
(AREA)
Peptides Or Proteins
(AREA)
Abstract
Det er gitt nukleinsyre- og proteinblandinger fra B. pertussis, som kan finne anvendelse i diagnostikk, forebyggelse og terapi av kikhoste. Spesielt kan en åpen leseramme som koder for filament-hemagglutininforlopere, utstyrt med det intakte protein for filament-hemagglutinin-delen av dette, uttrykkes i en lang rekke verter, til anvendelse i produksjon av antistoffer til immunodiagnostikk eller terapi, eller som vaksiner for profylak- tiske formål.Nucleic acid and protein mixtures from B. pertussis have been provided, which can be used in the diagnosis, prevention and therapy of whooping cough. In particular, an open reading frame encoding filament-hemagglutinin precursors, provided with the intact protein for the filament-hemagglutinin portion thereof, may be expressed in a wide variety of hosts, for use in the production of antibodies for immunodiagnostics or therapy, or as vaccines for prophylaxis. tical purposes.
NO91911673A1988-10-271991-04-26
FILAMENT - HEMAGGLUTININ OF B. PERTUSSIS.
NO911673L
(en)
9ALFA, 11ALFA-EPOXY-20-SPIROXANES AND ANALOGUES THEREOF WITH THE OPEN TETRAHYDROFURANRING E AND THEIR PREPARATION AND PHARMACEUTICAL PREPARATIONS CONTAINING THEM
SULFATED K5 ANTIGEN AND SULFATED K5 ANTIGEN FRAGMENTS AND PROCEDURES FOR PREPARING THEREOF AND SUBSTANCES CONTAINING THE SULFATED K5 ANTIGEN OR FRAGMENTS THEREOF
AZABICYCLO (3,3,1) NONANE-9 ONES OR STEREOISOMERS OR PHARMACEUTICAL ACCEPTABLE ACID ADDITION SALTS THEREOF, THEIR PREPARATION AND APPLICATION AND INTERMEDIATE PRODUCTS